Among others, the Handelsblatt reports on a major milestone achieved by AC Immune, in which MIG is invested through its portfolio company Affiris, in its mission to develop an effective drug for the as yet incurable Parkinson’s disease.

Several international trade media outlets are reporting on MIG’s investment in the French deep tech start-up NcodiN.

“Venture Capital Journal” presents, in an in-depth feature, the opportunities in the animal health market for VC investors, including quotes from Andreas Kastenbauer, Partner at MIG Capital.

Article with a quote by Dr. Matthias Kromayer, Managing Partner at MIG Capital.

German and international media are reporting on MIG Capital’s investment in the Swiss veterinary medicine start-up Astra Therapeutics.

Guest article by Dr. Fei Tian, Principal at MIG Capital.